Could anti-HCV treatment prevent recurrence of hepatocellular carcinoma in HIV-infected patients? Two case reports

Highly active antiretroviral therapy (HAART) has proven long-term efficacy in human immunodeficiency virus (HIV) infection. Combination therapy with pegylated interferon and ribavirin has become the standard of care in patients with both hepatitis C virus (HCV) chronic hepatitis and HIV/HCV co-infec...

Full description

Saved in:
Bibliographic Details
Published inInfection Vol. 41; no. 1; pp. 199 - 202
Main Authors Cenderello, G., Pontali, E., Cassola, G., Torresin, A.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 01.02.2013
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Highly active antiretroviral therapy (HAART) has proven long-term efficacy in human immunodeficiency virus (HIV) infection. Combination therapy with pegylated interferon and ribavirin has become the standard of care in patients with both hepatitis C virus (HCV) chronic hepatitis and HIV/HCV co-infection. Data on the safety and efficacy of combination therapy in chronic hepatitis C patients with hepatocellular carcinoma (HCC) is scarce and even more so in HIV/HCV co-infected subjects. We report the successful administration of both HAART and anti-HCV therapies in two HIV/HCV co-infected patients after HCC eradication. These encouraging results might argue for the feasibility of an aggressive approach in the management of co-infected patients with HCC.
AbstractList Highly active antiretroviral therapy (HAART) has proven long-term efficacy in human immunodeficiency virus (HIV) infection. Combination therapy with pegylated interferon and ribavirin has become the standard of care in patients with both hepatitis C virus (HCV) chronic hepatitis and HIV/HCV co-infection. Data on the safety and efficacy of combination therapy in chronic hepatitis C patients with hepatocellular carcinoma (HCC) is scarce and even more so in HIV/HCV co-infected subjects. We report the successful administration of both HAART and anti-HCV therapies in two HIV/HCV co-infected patients after HCC eradication. These encouraging results might argue for the feasibility of an aggressive approach in the management of co-infected patients with HCC.
Highly active antiretroviral therapy (HAART) has proven long-term efficacy in human immunodeficiency virus (HIV) infection. Combination therapy with pegylated interferon and ribavirin has become the standard of care in patients with both hepatitis C virus (HCV) chronic hepatitis and HIV/HCV co-infection. Data on the safety and efficacy of combination therapy in chronic hepatitis C patients with hepatocellular carcinoma (HCC) is scarce and even more so in HIV/HCV co-infected subjects. We report the successful administration of both HAART and anti-HCV therapies in two HIV/HCV co-infected patients after HCC eradication. These encouraging results might argue for the feasibility of an aggressive approach in the management of co-infected patients with HCC.Highly active antiretroviral therapy (HAART) has proven long-term efficacy in human immunodeficiency virus (HIV) infection. Combination therapy with pegylated interferon and ribavirin has become the standard of care in patients with both hepatitis C virus (HCV) chronic hepatitis and HIV/HCV co-infection. Data on the safety and efficacy of combination therapy in chronic hepatitis C patients with hepatocellular carcinoma (HCC) is scarce and even more so in HIV/HCV co-infected subjects. We report the successful administration of both HAART and anti-HCV therapies in two HIV/HCV co-infected patients after HCC eradication. These encouraging results might argue for the feasibility of an aggressive approach in the management of co-infected patients with HCC.
Author Torresin, A.
Cenderello, G.
Pontali, E.
Cassola, G.
Author_xml – sequence: 1
  givenname: G.
  surname: Cenderello
  fullname: Cenderello, G.
  organization: Department of Infectious Diseases, EO Ospedali Galliera
– sequence: 2
  givenname: E.
  surname: Pontali
  fullname: Pontali, E.
  email: pontals@yahoo.com
  organization: Department of Infectious Diseases, EO Ospedali Galliera
– sequence: 3
  givenname: G.
  surname: Cassola
  fullname: Cassola, G.
  organization: Department of Infectious Diseases, EO Ospedali Galliera
– sequence: 4
  givenname: A.
  surname: Torresin
  fullname: Torresin, A.
  organization: Department of Infectious Diseases, EO Ospedali Galliera
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23065464$$D View this record in MEDLINE/PubMed
BookMark eNqFkkFrFTEUhYNU7Gv1B7iRgBs3ozfJJJOsRB62r1BwU7sNeXl3dMpMMiYZxX9vhteCFKyrk8V3DvfenDNyEmJAQl4zeM8Aug-ZSWDQAOMNCCka8YxsWCtMA6YTJ2QDAqDRjKtTcpbzHQBI03YvyCkXoGSr2g1J27iMB-pCGZrd9paWhK5MGAqdE_5cNaFfUsLgkcaefsfZlehxHJfRJepd8kOIk6NDoLur22YIPfqCB1qxodrzR3rzK1YuY02aYyr5JXneuzHjq3s9J18vPt9sd831l8ur7afrxrdClEaYVjFQvuq-LrUHyTSi51xrKdHIvnWdMF2n-r7lojeMI7q9UkbXJzuAOCfvjrlzij8WzMVOQ14ndwHjki0TXGgAbfT_Ua7ruaQGVdG3j9C7uKRQF7FcGdlpKbruKapmtdJIpdYJ39xTy37Cg53TMLn02z58TwW6I-BTzDlhb_1Q6mFjKMkNo2Vg1yLYYxFsLYJdi2BFdbJHzofwpzz86MmVDd8w_TX0P01_ACi6wYw
CitedBy_id crossref_primary_10_1007_s40278_014_9343_9
Cites_doi 10.1053/jhep.2000.9409
10.3748/wjg.14.6140
10.1016/j.jhep.2010.07.011
10.1310/6ULM-XYB7-H4XP-BHFJ
10.1634/theoncologist.2010-0400
10.1002/hep.21415
10.1097/QAD.0b013e3281084e4d
10.1111/j.1872-034X.2007.00200.x
10.1056/NEJM199803263381301
10.1056/NEJMoa040842
10.1097/00002030-200411190-00009
10.1001/jama.279.6.450
10.1002/hep.20626
10.1046/j.0007-1323.2001.02054.x
10.1016/j.jhep.2007.06.010
10.1016/S0140-6736(98)07236-5
10.1016/j.dld.2009.08.001
10.1053/gast.2002.33411
10.1111/j.1440-1746.2005.03925.x
10.1093/jac/dkh031
10.3748/wjg.14.1657
10.1097/01.aids.0000194799.43799.ea
10.1002/cncr.20004
10.1016/S1542-3565(05)00713-5
10.1053/j.gastro.2004.09.044
10.7326/0003-4819-138-4-200302180-00008
10.1016/S0002-9270(00)02167-5
10.7326/0003-4819-142-2-200501180-00009
10.7326/0003-4819-134-10-200105150-00010
ContentType Journal Article
Copyright Springer-Verlag Berlin Heidelberg 2012
Springer-Verlag Berlin Heidelberg 2012.
Copyright_xml – notice: Springer-Verlag Berlin Heidelberg 2012
– notice: Springer-Verlag Berlin Heidelberg 2012.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7RV
7U9
7X7
7XB
88E
8AO
8C1
8FD
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
BENPR
C1K
CCPQU
FR3
FYUFA
GHDGH
H94
K9.
KB0
M0S
M1P
M7N
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
RC3
7X8
DOI 10.1007/s15010-012-0353-3
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database ProQuest
Algology Mycology and Protozoology Abstracts (Microbiology C)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE - Academic
MEDLINE
Technology Research Database

Technology Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1439-0973
EndPage 202
ExternalDocumentID 2885240061
23065464
10_1007_s15010_012_0353_3
Genre Journal Article
Case Reports
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
04C
06C
06D
0R~
0VY
199
1N0
1SB
203
28-
29I
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
78A
7RV
7X7
88E
8AO
8C1
8FI
8FJ
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACZOJ
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEUYN
AEVLU
AEXYK
AFBBN
AFEXP
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIHBH
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P9S
PCD
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
RNS
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
Y6R
YLTOR
Z45
Z7U
Z82
Z87
Z8O
Z8V
Z91
ZGI
ZMTXR
ZOVNA
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7QL
7U9
7XB
8FD
8FK
C1K
FR3
H94
K9.
M7N
P64
PKEHL
PQEST
PQUKI
RC3
7X8
ID FETCH-LOGICAL-c433t-3946106c394b143b0518eec228855e95f4a739776ff423f912eeab66989121d03
IEDL.DBID U2A
ISSN 0300-8126
1439-0973
IngestDate Fri Jul 11 09:33:43 EDT 2025
Fri Jul 11 03:57:45 EDT 2025
Sat Aug 16 18:41:06 EDT 2025
Sat Aug 16 02:52:36 EDT 2025
Mon Jul 21 05:57:16 EDT 2025
Tue Jul 01 04:29:17 EDT 2025
Thu Apr 24 23:14:03 EDT 2025
Fri Feb 21 02:45:21 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords White Blood Cell Decrease
Start Combination Treatment
Human Immunodeficiency Virus
Sustained Virological Response
Nelfinavir
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c433t-3946106c394b143b0518eec228855e95f4a739776ff423f912eeab66989121d03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ObjectType-Article-2
ObjectType-Feature-1
PMID 23065464
PQID 1284595660
PQPubID 29907
PageCount 4
ParticipantIDs proquest_miscellaneous_1323800898
proquest_miscellaneous_1285465806
proquest_journals_2695785377
proquest_journals_1284595660
pubmed_primary_23065464
crossref_citationtrail_10_1007_s15010_012_0353_3
crossref_primary_10_1007_s15010_012_0353_3
springer_journals_10_1007_s15010_012_0353_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20130200
2013-02-00
2013-Feb
20130201
PublicationDateYYYYMMDD 2013-02-01
PublicationDate_xml – month: 2
  year: 2013
  text: 20130200
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: New York
PublicationSubtitle A Journal of Infectious Disease
PublicationTitle Infection
PublicationTitleAbbrev Infection
PublicationTitleAlternate Infection
PublicationYear 2013
Publisher Springer-Verlag
Springer Nature B.V
Publisher_xml – name: Springer-Verlag
– name: Springer Nature B.V
References Kubo, Nishiguchi, Hirohashi (CR27) 2002; 89
Palella, Delaney, Moorman (CR2) 1998; 338
Shiratori, Shiina, Teratani (CR25) 2003; 138
García-Samaniego, Rodríguez, Berenguer (CR20) 2001; 96
Torriani, Rodriguez-Torres, Rockstroh (CR6) 2004; 351
Befeler, Di Bisceglie (CR16) 2002; 122
Bräu, Fox, Xiao (CR19) 2007; 47
Omata, Yoshida, Shiratori (CR13) 2005; 3
Huang, Yu, Huang (CR15) 2011; 54
Berretta, Garlassi, Cacopardo (CR21) 2011; 16
Lin, Lin, Hsu (CR26) 2004; 100
Heathcote (CR11) 2004; 127
Shiratori, Ito, Yokosuka (CR22) 2005; 142
Hino, Okita (CR10) 2004; 53
Mazzaferro, Romito, Schiavo (CR29) 2006; 44
Ikeda, Arase, Saitoh (CR23) 2000; 32
Mocroft, Soriano, Rockstroh (CR5) 2005; 19
Hogg, Yip, Kully (CR3) 1999; 160
Hung, Lee, Wang (CR12) 2005; 20
(CR14) 2010; 42
Soriano, Puoti, Sulkowski (CR7) 2007; 21
CR8
Ishikawa (CR31) 2008; 14
Puoti, Bruno, Soriano (CR18) 2004; 18
(CR28) 1998; 351
Floridia, Massella, Bucciardini (CR4) 2000; 1
Abbas, Siddiqui, Luck (CR32) 2008; 58
Kubo, Nishiguchi, Hirohashi (CR24) 2001; 134
Macdonald, Nelson, Bower (CR9) 2008; 14
Wright (CR30) 2007; 37
Hogg, Heath, Yip (CR1) 1998; 279
Pineda, Romero-Gómez, Díaz-García (CR17) 2005; 41
S Kubo (353_CR27) 2002; 89
RS Hogg (353_CR3) 1999; 160
K Hino (353_CR10) 2004; 53
CH Hung (353_CR12) 2005; 20
A Mocroft (353_CR5) 2005; 19
N Bräu (353_CR19) 2007; 47
DC Macdonald (353_CR9) 2008; 14
V Mazzaferro (353_CR29) 2006; 44
TL Wright (353_CR30) 2007; 37
International Interferon-alpha Hepatocellular Carcinoma Study Group (353_CR28) 1998; 351
T Ishikawa (353_CR31) 2008; 14
M Berretta (353_CR21) 2011; 16
JF Huang (353_CR15) 2011; 54
S Kubo (353_CR24) 2001; 134
SM Lin (353_CR26) 2004; 100
J García-Samaniego (353_CR20) 2001; 96
RS Hogg (353_CR1) 1998; 279
Y Shiratori (353_CR22) 2005; 142
Z Abbas (353_CR32) 2008; 58
JA Pineda (353_CR17) 2005; 41
Italian Association for the Study of the Liver (353_CR14) 2010; 42
353_CR8
FJ Palella Jr (353_CR2) 1998; 338
V Soriano (353_CR7) 2007; 21
FJ Torriani (353_CR6) 2004; 351
M Omata (353_CR13) 2005; 3
AS Befeler (353_CR16) 2002; 122
M Puoti (353_CR18) 2004; 18
M Floridia (353_CR4) 2000; 1
EJ Heathcote (353_CR11) 2004; 127
K Ikeda (353_CR23) 2000; 32
Y Shiratori (353_CR25) 2003; 138
10326535 - Lancet. 1998 May 23;351(9115):1535-9
19024130 - J Pak Med Assoc. 2008 Nov;58(11):602-7
11352697 - Ann Intern Med. 2001 May 15;134(10):963-7
15577541 - AIDS. 2004 Nov 19;18(17):2285-93
14716774 - Cancer. 2004 Jan 15;100(2):376-82
18350596 - World J Gastroenterol. 2008 Mar 21;14(11):1657-63
15508097 - Gastroenterology. 2004 Nov;127(5 Suppl 1):S294-302
16284461 - AIDS. 2005 Dec 2;19(18):2117-25
11197250 - Am J Gastroenterol. 2001 Jan;96(1):179-83
15800956 - Hepatology. 2005 Apr;41(4):779-89
10102000 - CMAJ. 1999 Mar 9;160(5):659-65
17133492 - Hepatology. 2006 Dec;44(6):1543-54
21056500 - J Hepatol. 2011 Feb;54(2):219-26
14657083 - J Antimicrob Chemother. 2004 Jan;53(1):19-22
9466638 - JAMA. 1998 Feb 11;279(6):450-4
11952580 - Br J Surg. 2002 Apr;89(4):418-22
11590493 - HIV Clin Trials. 2000 Sep-Oct;1(2):9-16
19748329 - Dig Liver Dis. 2010 Feb;42(2):81-91
16174073 - J Gastroenterol Hepatol. 2005 Oct;20(10 ):1553-9
17502718 - AIDS. 2007 May 31;21(9):1073-89
16234063 - Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S141-3
15657158 - Ann Intern Med. 2005 Jan 18;142(2):105-14
15282351 - N Engl J Med. 2004 Jul 29;351(5):438-50
17877498 - Hepatol Res. 2007 Sep;37 Suppl 2:S294-8
12016426 - Gastroenterology. 2002 May;122(6):1609-19
21868692 - Oncologist. 2011;16(9):1258-69
17692986 - J Hepatol. 2007 Oct;47(4):527-37
10915728 - Hepatology. 2000 Aug;32(2):228-32
12585827 - Ann Intern Med. 2003 Feb 18;138(4):299-306
9516219 - N Engl J Med. 1998 Mar 26;338(13):853-60
18985803 - World J Gastroenterol. 2008 Oct 28;14(40):6140-4
References_xml – volume: 32
  start-page: 228
  year: 2000
  end-page: 232
  ident: CR23
  article-title: Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—a prospective randomized study of hepatitis C virus-related liver cancer
  publication-title: Hepatology
  doi: 10.1053/jhep.2000.9409
– volume: 14
  start-page: 6140
  year: 2008
  end-page: 6144
  ident: CR31
  article-title: Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.14.6140
– volume: 54
  start-page: 216
  year: 2011
  end-page: 226
  ident: CR15
  article-title: The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis C patients with hepatocellular carcinoma post curative therapies—a multicenter prospective trial
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2010.07.011
– volume: 1
  start-page: 9
  year: 2000
  end-page: 16
  ident: CR4
  article-title: Hospitalizations and costs of treatment for protease inhibitor-based regimens in patients with very advanced HIV-infection (CD4 < 50/mm )
  publication-title: HIV Clin Trials
  doi: 10.1310/6ULM-XYB7-H4XP-BHFJ
– volume: 16
  start-page: 1258
  year: 2011
  end-page: 1269
  ident: CR21
  article-title: Hepatocellular carcinoma in HIV-infected patients: check early, treat hard
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2010-0400
– volume: 44
  start-page: 1543
  year: 2006
  end-page: 1554
  ident: CR29
  article-title: Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis
  publication-title: Hepatology
  doi: 10.1002/hep.21415
– volume: 21
  start-page: 1073
  year: 2007
  end-page: 1089
  ident: CR7
  article-title: Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e3281084e4d
– volume: 37
  start-page: S294
  issue: Suppl 2
  year: 2007
  end-page: S298
  ident: CR30
  article-title: Antiviral therapy and primary and secondary prevention of hepatocellular carcinoma
  publication-title: Hepatol Res
  doi: 10.1111/j.1872-034X.2007.00200.x
– volume: 338
  start-page: 853
  year: 1998
  end-page: 860
  ident: CR2
  article-title: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199803263381301
– volume: 351
  start-page: 438
  year: 2004
  end-page: 450
  ident: CR6
  article-title: Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa040842
– volume: 160
  start-page: 659
  year: 1999
  end-page: 665
  ident: CR3
  article-title: Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens
  publication-title: CMAJ
– volume: 18
  start-page: 2285
  year: 2004
  end-page: 2293
  ident: CR18
  article-title: Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome
  publication-title: AIDS
  doi: 10.1097/00002030-200411190-00009
– volume: 279
  start-page: 450
  year: 1998
  end-page: 454
  ident: CR1
  article-title: Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
  publication-title: JAMA
  doi: 10.1001/jama.279.6.450
– ident: CR8
– volume: 41
  start-page: 779
  year: 2005
  end-page: 789
  ident: CR17
  article-title: HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis
  publication-title: Hepatology
  doi: 10.1002/hep.20626
– volume: 138
  start-page: 299
  year: 2003
  end-page: 306
  ident: CR25
  article-title: Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus
  publication-title: Ann Intern Med
– volume: 89
  start-page: 418
  year: 2002
  end-page: 422
  ident: CR27
  article-title: Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy
  publication-title: Br J Surg
  doi: 10.1046/j.0007-1323.2001.02054.x
– volume: 47
  start-page: 527
  year: 2007
  end-page: 537
  ident: CR19
  article-title: Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2007.06.010
– volume: 351
  start-page: 1535
  year: 1998
  end-page: 1539
  ident: CR28
  article-title: Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)07236-5
– volume: 42
  start-page: 81
  year: 2010
  end-page: 91
  ident: CR14
  article-title: Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting
  publication-title: Dig Liver Dis
  doi: 10.1016/j.dld.2009.08.001
– volume: 122
  start-page: 1609
  year: 2002
  end-page: 1619
  ident: CR16
  article-title: Hepatocellular carcinoma: diagnosis and treatment
  publication-title: Gastroenterology
  doi: 10.1053/gast.2002.33411
– volume: 96
  start-page: 179
  year: 2001
  end-page: 183
  ident: CR20
  article-title: Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C
  publication-title: Am J Gastroenterol
– volume: 20
  start-page: 1553
  year: 2005
  end-page: 1559
  ident: CR12
  article-title: Antiviral therapy after non-surgical tumor ablation in patients with hepatocellular carcinoma associated with hepatitis C virus
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2005.03925.x
– volume: 53
  start-page: 19
  year: 2004
  end-page: 22
  ident: CR10
  article-title: Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis C
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkh031
– volume: 14
  start-page: 1657
  year: 2008
  end-page: 1663
  ident: CR9
  article-title: Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.14.1657
– volume: 142
  start-page: 105
  year: 2005
  end-page: 114
  ident: CR22
  article-title: Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival
  publication-title: Ann Intern Med
– volume: 58
  start-page: 602
  year: 2008
  end-page: 607
  ident: CR32
  article-title: Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology
  publication-title: J Pak Med Assoc
– volume: 19
  start-page: 2117
  year: 2005
  end-page: 2125
  ident: CR5
  article-title: Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
  publication-title: AIDS
  doi: 10.1097/01.aids.0000194799.43799.ea
– volume: 100
  start-page: 376
  year: 2004
  end-page: 382
  ident: CR26
  article-title: Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors
  publication-title: Cancer
  doi: 10.1002/cncr.20004
– volume: 134
  start-page: 963
  year: 2001
  end-page: 967
  ident: CR24
  article-title: Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial
  publication-title: Ann Intern Med
– volume: 3
  start-page: S141
  issue: 10 Suppl 2
  year: 2005
  end-page: S143
  ident: CR13
  article-title: Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/S1542-3565(05)00713-5
– volume: 127
  start-page: S294
  issue: 5 Suppl 1
  year: 2004
  end-page: S302
  ident: CR11
  article-title: Prevention of hepatitis C virus-related hepatocellular carcinoma
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2004.09.044
– volume: 32
  start-page: 228
  year: 2000
  ident: 353_CR23
  publication-title: Hepatology
  doi: 10.1053/jhep.2000.9409
– volume: 279
  start-page: 450
  year: 1998
  ident: 353_CR1
  publication-title: JAMA
  doi: 10.1001/jama.279.6.450
– volume: 16
  start-page: 1258
  year: 2011
  ident: 353_CR21
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2010-0400
– volume: 14
  start-page: 1657
  year: 2008
  ident: 353_CR9
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.14.1657
– volume: 18
  start-page: 2285
  year: 2004
  ident: 353_CR18
  publication-title: AIDS
  doi: 10.1097/00002030-200411190-00009
– volume: 160
  start-page: 659
  year: 1999
  ident: 353_CR3
  publication-title: CMAJ
– volume: 41
  start-page: 779
  year: 2005
  ident: 353_CR17
  publication-title: Hepatology
  doi: 10.1002/hep.20626
– volume: 138
  start-page: 299
  year: 2003
  ident: 353_CR25
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-138-4-200302180-00008
– volume: 44
  start-page: 1543
  year: 2006
  ident: 353_CR29
  publication-title: Hepatology
  doi: 10.1002/hep.21415
– volume: 54
  start-page: 216
  year: 2011
  ident: 353_CR15
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2010.07.011
– volume: 53
  start-page: 19
  year: 2004
  ident: 353_CR10
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkh031
– volume: 58
  start-page: 602
  year: 2008
  ident: 353_CR32
  publication-title: J Pak Med Assoc
– volume: 19
  start-page: 2117
  year: 2005
  ident: 353_CR5
  publication-title: AIDS
  doi: 10.1097/01.aids.0000194799.43799.ea
– volume: 14
  start-page: 6140
  year: 2008
  ident: 353_CR31
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.14.6140
– volume: 37
  start-page: S294
  issue: Suppl 2
  year: 2007
  ident: 353_CR30
  publication-title: Hepatol Res
  doi: 10.1111/j.1872-034X.2007.00200.x
– volume: 100
  start-page: 376
  year: 2004
  ident: 353_CR26
  publication-title: Cancer
  doi: 10.1002/cncr.20004
– volume: 1
  start-page: 9
  year: 2000
  ident: 353_CR4
  publication-title: HIV Clin Trials
  doi: 10.1310/6ULM-XYB7-H4XP-BHFJ
– volume: 351
  start-page: 438
  year: 2004
  ident: 353_CR6
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa040842
– volume: 351
  start-page: 1535
  year: 1998
  ident: 353_CR28
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)07236-5
– volume: 20
  start-page: 1553
  year: 2005
  ident: 353_CR12
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2005.03925.x
– volume: 42
  start-page: 81
  year: 2010
  ident: 353_CR14
  publication-title: Dig Liver Dis
  doi: 10.1016/j.dld.2009.08.001
– ident: 353_CR8
– volume: 47
  start-page: 527
  year: 2007
  ident: 353_CR19
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2007.06.010
– volume: 89
  start-page: 418
  year: 2002
  ident: 353_CR27
  publication-title: Br J Surg
  doi: 10.1046/j.0007-1323.2001.02054.x
– volume: 96
  start-page: 179
  year: 2001
  ident: 353_CR20
  publication-title: Am J Gastroenterol
  doi: 10.1016/S0002-9270(00)02167-5
– volume: 122
  start-page: 1609
  year: 2002
  ident: 353_CR16
  publication-title: Gastroenterology
  doi: 10.1053/gast.2002.33411
– volume: 142
  start-page: 105
  year: 2005
  ident: 353_CR22
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-142-2-200501180-00009
– volume: 134
  start-page: 963
  year: 2001
  ident: 353_CR24
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-134-10-200105150-00010
– volume: 338
  start-page: 853
  year: 1998
  ident: 353_CR2
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199803263381301
– volume: 3
  start-page: S141
  issue: 10 Suppl 2
  year: 2005
  ident: 353_CR13
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/S1542-3565(05)00713-5
– volume: 127
  start-page: S294
  issue: 5 Suppl 1
  year: 2004
  ident: 353_CR11
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2004.09.044
– volume: 21
  start-page: 1073
  year: 2007
  ident: 353_CR7
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e3281084e4d
– reference: 10102000 - CMAJ. 1999 Mar 9;160(5):659-65
– reference: 17133492 - Hepatology. 2006 Dec;44(6):1543-54
– reference: 11590493 - HIV Clin Trials. 2000 Sep-Oct;1(2):9-16
– reference: 11952580 - Br J Surg. 2002 Apr;89(4):418-22
– reference: 14716774 - Cancer. 2004 Jan 15;100(2):376-82
– reference: 16284461 - AIDS. 2005 Dec 2;19(18):2117-25
– reference: 15657158 - Ann Intern Med. 2005 Jan 18;142(2):105-14
– reference: 12585827 - Ann Intern Med. 2003 Feb 18;138(4):299-306
– reference: 14657083 - J Antimicrob Chemother. 2004 Jan;53(1):19-22
– reference: 21868692 - Oncologist. 2011;16(9):1258-69
– reference: 16174073 - J Gastroenterol Hepatol. 2005 Oct;20(10 ):1553-9
– reference: 15282351 - N Engl J Med. 2004 Jul 29;351(5):438-50
– reference: 12016426 - Gastroenterology. 2002 May;122(6):1609-19
– reference: 15800956 - Hepatology. 2005 Apr;41(4):779-89
– reference: 18350596 - World J Gastroenterol. 2008 Mar 21;14(11):1657-63
– reference: 15508097 - Gastroenterology. 2004 Nov;127(5 Suppl 1):S294-302
– reference: 18985803 - World J Gastroenterol. 2008 Oct 28;14(40):6140-4
– reference: 17502718 - AIDS. 2007 May 31;21(9):1073-89
– reference: 19748329 - Dig Liver Dis. 2010 Feb;42(2):81-91
– reference: 11352697 - Ann Intern Med. 2001 May 15;134(10):963-7
– reference: 17877498 - Hepatol Res. 2007 Sep;37 Suppl 2:S294-8
– reference: 10326535 - Lancet. 1998 May 23;351(9115):1535-9
– reference: 10915728 - Hepatology. 2000 Aug;32(2):228-32
– reference: 11197250 - Am J Gastroenterol. 2001 Jan;96(1):179-83
– reference: 9516219 - N Engl J Med. 1998 Mar 26;338(13):853-60
– reference: 15577541 - AIDS. 2004 Nov 19;18(17):2285-93
– reference: 16234063 - Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S141-3
– reference: 9466638 - JAMA. 1998 Feb 11;279(6):450-4
– reference: 17692986 - J Hepatol. 2007 Oct;47(4):527-37
– reference: 21056500 - J Hepatol. 2011 Feb;54(2):219-26
– reference: 19024130 - J Pak Med Assoc. 2008 Nov;58(11):602-7
SSID ssj0005947
Score 1.9694779
Snippet Highly active antiretroviral therapy (HAART) has proven long-term efficacy in human immunodeficiency virus (HIV) infection. Combination therapy with pegylated...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 199
SubjectTerms Antiretroviral agents
Antiretroviral Therapy, Highly Active
Antiviral Agents - administration & dosage
Antiviral Agents - adverse effects
Antiviral Agents - therapeutic use
Brief Report
Carcinoma, Hepatocellular - prevention & control
Case reports
Chronic infection
Coinfection
Family Medicine
General Practice
Hepatitis
Hepatitis C
Hepatitis C virus
Hepatitis C, Chronic - drug therapy
Hepatocellular carcinoma
Highly active antiretroviral therapy
HIV
HIV Infections - drug therapy
Human immunodeficiency virus
Humans
Infectious Diseases
Interferon
Internal Medicine
Liver cancer
Liver Neoplasms - prevention & control
Male
Medicine
Medicine & Public Health
Middle Aged
Patients
Recurrence
Ribavirin
Therapy
Treatment Outcome
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BkRCXivIZKJWROIEskjhx4lOFVlQLUjm11d4iJx6LSpBsd7fi7zPjOLugwp5yiBM5nrFn7Hl5D-Cd83WnbVHR3qQysnDYSYtlwDQo6ykG-UDHcP5Nzy-Lr4tyEQ_c1hFWOa2JYaF2Q8dn5B9zbZiXRVXV6fJGsmoUV1ejhMZ9eMDUZQzpqhbVDuJhgsAY-XEqKZDpqaoZfp0rQxmYgQmqVFL9HZfuJJt3CqUh_pw9hsOYOIpPo6WP4B72T-DheSyNP4XVjMWqBQ3UtZzPrsQWQS6WI0uTWPHRevi5TwxefKc4tBn43J6BqKJjTaF--GnFdS_mX67kiNJCJyLz6vpUXPwaqN0aRSw0PIPLs88Xs7mMggqyK5TaSGWYXV13dG0pT2ppQtaIXZ7XdVmiKX1hK04ItfeUZXmT5Yi21awxmeWZS9VzOOiHHl-C8FlLMS9DZ1ssjDO2Rk_rgXPKp9i6NoF0Gs6mi2zjLHrxo9nxJLMFGrJAwxZoVALvt48sR6qNfY2PJxs1cdatG461JW34dPrP2zsXSuDt9jZNJx5r2-NwG17B8vB1qve0UZTnUO5k6gRejO6x7TDv6OgFRQIfJn_5o3__-5pX-7v7Gh7lQYWDUTTHcLBZ3eIbyoU27Ulw-N-4tAM1
  priority: 102
  providerName: ProQuest
Title Could anti-HCV treatment prevent recurrence of hepatocellular carcinoma in HIV-infected patients? Two case reports
URI https://link.springer.com/article/10.1007/s15010-012-0353-3
https://www.ncbi.nlm.nih.gov/pubmed/23065464
https://www.proquest.com/docview/1284595660
https://www.proquest.com/docview/2695785377
https://www.proquest.com/docview/1285465806
https://www.proquest.com/docview/1323800898
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_WFsZexrpPb23QYE8bAtuyZetpJCFZttEwRlOyJyNbEiu0dklS9u_vTraTlX7AXqwHn4WsO-l-pzvdAXwwLq-kTjK0TTLFE2Mrrm3qYxqEdqiDnE_HcDKXs0XybZkuu3vc6z7avXdJ-p16d9kt9Y5bCiUQqeBiDw5SMt1RiBfxcBfXoXxVMRTekKP2kr0r864ubiqjWwjzlnfUK53pM3jaoUU2bNl7CI9s_Rwen3T-8BewGlOFaoazc85n4zO2DRtnV21qJrai83R_o481jv1G5bNp6LCeok9ZRYWE6uZSs_Oazb6e8TY0yxrWpVtdf2anfxqkW1vWeRdewmI6OR3PeFdFgVeJEBsuFKVUlxW2JYKjEldhbm0Vx3meplalLtEZoUDpHEIrp6LYWl1KKiwZxZEJxSvYr5vavgHmohIVXWSNLm2ijNK5dbgJGCNcaEtTBhD201lUXYpxqnRxUeySIxMHCuRAQRwoRAAft59ctfk1HiI-6nlUdEttXZCCTdHKk-Gdr2OpKJ-PyLIA3m9f4xqiuda1ba59F1QTPg_lAzQCwQ0CJpUH8LoVj-2AyYzDDpIAPvXy8s_47vubt_9F_Q6exL4SB0XSHMH-ZnVtjxEPbcoB7GXLDJ_5OBrAwXA6Gs2p_fLr-wTb0WT-4-fAr5G_kMwFzA
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8CBYwEF5BFEuflA6pgaZWl3RVC26q31IltUQmSZXerij_Fb2TGSXZBhb31lEMcy_GMPTOe8fcBvNQ2qxIVpRibpJJH2lRcmdjVNAhl0QZZB8cwniT5UfTpJD7Zgl_9XRgqq-z3RLdR66aiM_K3YSIJl0Wk6e7sByfWKMqu9hQarVocmJ8XGLIt3o0-onxfheH-3nSY845VgFeREEsuJEGMJxU-S3QWStTKzJgqDLMsjo2MbaRS8ooSa9HVsDIIjVFlQkSLQRhoX2C_12A7EhjKDGD7w97k85d1UYl0lGa4cnyOpjPp86jusl7sEs9UCiFiwcXflvCSe3spNess3v5tuNW5qux9q1t3YMvUd-H6uEvG34P5kOixGYrmjOfDY7aqWWezFheKzekw310nZI1lX9HyLRvKFFDpK6uIxahuvit2VrN8dMzbujCjWYf1uthl04sG2y0M61Ib9-HoSib7AQzqpjaPgNmgRCsbGK1KE0ktVWYs7kBaC-ubUpce-P10FlWHb040G9-KNTIzSaBACRQkgUJ48Hr1yawF99jUeKeXUdGt80VB1j3GEDPx__l6rbQevFi9xgVMc61q05y7LoiQPvOTDW0EelborcnMg4eteqwGTDEkdhB58KbXlz_G97-_ebx5uM_hRj4dHxaHo8nBE7gZOg4QquHZgcFyfm6eoie2LJ916s_g9KpX3G-TtT7E
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VIlVcKspnoICR4AKymsSxkxxQVW1Z7VJacWirvQUntkWlkiy7W1X8NX4dM06yCyrsracc4liOZ8Yz9jzPA3hjXFYpnaS4N0lznhhbcW2lxzQI7dAHOV-O4fhEjc6STxM52YBf_V0YglX2a6JfqE1T0Rn5Xqxyqssi0nTPdbCIL4fD_ekPTgxSlGnt6TRaFTmyP69x-zb_MD5EWb-N4-HH08GIdwwDvEqEWHCRU7lxVeGzxMChRA3NrK3iOMuktLl0iU4pQlLOYdjh8ii2VpeKSBejODKhwH7vwN1UyIhsLJ2kK3hJ7snN0IZCjk5U9RlVf21P-hQ0gSKEFFz87RNvBLo3krTe9w3vw3YXtLKDVst2YMPWD2DruEvLP4TZgIiyGQrpgo8G52yJXmfTtkIUm9Gxvr9YyBrHvqEPXDSUMyAQLKuIz6huvmt2UbPR-Jy3CDFrWFf1db7PTq8bbDe3rEtyPIKzW5nqx7BZN7V9CsxFJfrbyBpd2iQ3uc6sw7XIGOFCW5oygLCfzqLqKp0T4cZlsarRTBIoUAIFSaAQAbxbfjJty3ysa7zby6joLH5ekJ-XuNlU4T9fr9Q3gNfL12jKNNe6ts2V74Ko6bNQrWkjMMbCuC3PAnjSqsdywLSbxA6SAN73-vLH-P73N8_WD_cVbKGdFZ_HJ0fP4V7syUAIzLMLm4vZlX2BIdmifOl1n8HX2za23z6ZQZQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Could+anti-HCV+treatment+prevent+recurrence+of+hepatocellular+carcinoma+in+HIV-infected+patients%3F+Two+case+reports&rft.jtitle=Infection&rft.au=Cenderello%2C+G.&rft.au=Pontali%2C+E.&rft.au=Cassola%2C+G.&rft.au=Torresin%2C+A.&rft.date=2013-02-01&rft.pub=Springer-Verlag&rft.issn=0300-8126&rft.eissn=1439-0973&rft.volume=41&rft.issue=1&rft.spage=199&rft.epage=202&rft_id=info:doi/10.1007%2Fs15010-012-0353-3&rft.externalDocID=10_1007_s15010_012_0353_3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-8126&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-8126&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-8126&client=summon